ACTUATE THERAPEUTICS INC. - COMMON STOCK

8,5500

14-ноября-24 16:45:00

15 мин. задержка

Акции

-0,0100

-0,12%

Сегодняшний диапазон

8,3700 - 8,9800

ISIN

N/A

Источник

NASDAQ

Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

12 ноя 2024 08:00:03 Источник Nasdaq GlobeNewswire
Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

29 окт 2024 18:39:24 Источник Nasdaq GlobeNewswire
Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3β Inhibitor

23 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research

16 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas

11 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma

09 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference

05 сен 2024 09:10:56 Источник Nasdaq GlobeNewswire
Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024

20 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.